658 related articles for article (PubMed ID: 22258483)
21. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
22. Dermatomyositis and polymyositis: new treatment targets on the horizon.
Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
[TBL] [Abstract][Full Text] [Related]
23. Lung involvement associated with anti-NXP2 autoantibodies in inflammatory myopathies: a French monocenter series.
Bermudez J; Heim X; Bertin D; Coulon B; Puech B; Bardin N; Reynaud-Gaubert M
Expert Rev Respir Med; 2020 Aug; 14(8):845-850. PubMed ID: 32394768
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
[TBL] [Abstract][Full Text] [Related]
25. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Wang X; Ding Y; Zhou Z; Hou J; Xu Y; Li J
Pediatr Rheumatol Online J; 2021 Jan; 19(1):6. PubMed ID: 33407621
[TBL] [Abstract][Full Text] [Related]
27. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].
Victor J; Zanardo L; Héron-Mermin D; Poursac N; Solé G; Bordes C; Duffau P
Rev Med Interne; 2019 Feb; 40(2):70-81. PubMed ID: 30527961
[TBL] [Abstract][Full Text] [Related]
29. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.
Furuya T; Hakoda M; Tsuchiya N; Kotake S; Ichikawa N; Nanke Y; Nakajima A; Takeuchi M; Nishinarita M; Kondo H; Kawasaki A; Kobayashi S; Mimori T; Tokunaga K; Kamatani N
J Rheumatol; 2004 Sep; 31(9):1768-74. PubMed ID: 15338498
[TBL] [Abstract][Full Text] [Related]
30. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.
Chinoy H; Payne D; Poulton KV; Fertig N; Betteridge Z; Gunawardena H; Davidson JE; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
Rheumatology (Oxford); 2009 Oct; 48(10):1213-7. PubMed ID: 19690132
[TBL] [Abstract][Full Text] [Related]
31. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
[TBL] [Abstract][Full Text] [Related]
33. Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations.
So H; Ip RW; Wong VT; Yip RM
Int J Rheum Dis; 2018 May; 21(5):1076-1081. PubMed ID: 29380533
[TBL] [Abstract][Full Text] [Related]
34. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
36. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
[TBL] [Abstract][Full Text] [Related]
37. Multiple neurological manifestations in a patient with systemic lupus erythematosus and anti-NXP2-positive myositis: A case report.
Cao X; Zhang M; Lu Z; Li C; Zeng Y; Fan J; Yu K
Medicine (Baltimore); 2021 Mar; 100(10):e25063. PubMed ID: 33725895
[TBL] [Abstract][Full Text] [Related]
38. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
39. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
[TBL] [Abstract][Full Text] [Related]
40. Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
Konishi R; Ichimura Y; Tanaka R; Miyahara H; Okune M; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nakagishi Y; Mizuta M; Kaneko S; Shimizu M; Morio T; Nishino I; Nomura T; Okiyama N
Immunol Med; 2024 Jun; 47(2):100-105. PubMed ID: 38174692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
